Featured Research

from universities, journals, and other organizations

NSAIDs No Better Than Other Over-the-Counter Drugs for Low Back Pain

Date:
January 24, 2008
Source:
Center For The Advancement of Health
Summary:
When low back pain strikes, many people turn to non-steroidal anti-inflammatory drugs (NSAIDs), like naproxen and ibuprofen, or their newer COX-2 inhibitor cousin Celebrex. However, these drugs work no better than old faithful acetaminophen (Tylenol), according to a new review of studies. Review data “support guidelines for the management of low back pain in primary care that recommend NSAIDs as a treatment option after paracetamol has been tried, since there are fewer side effects with paracetamol,” said lead reviewer. Paracetamol is the European version of Tylenol.

When low back pain strikes, many people turn to non-steroidal anti-inflammatory drugs (NSAIDs), like naproxen and ibuprofen, or their newer COX-2 inhibitor cousin Celebrex. However, these drugs work no better than old faithful acetaminophen (Tylenol), according to a new review of studies.

Review data “support guidelines for the management of low back pain in primary care that recommend NSAIDs as a treatment option after paracetamol has been tried, since there are fewer side effects with paracetamol,” said lead reviewer Pepijn Roelofs. Paracetamol is the European version of Tylenol.

The researchers examined 65 studies, covering more than 11,000 low back pain sufferers. They concluded that NSAIDs are “slightly effective” for short-term symptomatic relief, allowing a return to normal activity in patients with acute and chronic low back pain without sciatica.

The review appears in the latest issue of The Cochrane Library, a publication of The Cochrane Collaboration, an international organization that evaluates medical research. Systematic reviews draw evidence-based conclusions about medical practice after considering both the content and quality of existing medical trials on a topic.

The authors cautioned doctors that while NSAIDs are appropriate for short-term use, improvements are small and it is unclear whether they work better than simple analgesics or other drugs. No kind of NSAID jumped out as any more effective than others are, either, in the studies reviewed.

Moreover, the data showed that NSAIDs were not superior to acetaminophen.

“Currently, the long-term use of NSAIDs is controversial because of cardiovascular adverse effects in patients with cardiovascular risk factors, such as previous angina pectoris, heart failure and myocardial infarction,” said Roelofs, a doctoral student at the Erasmus University Medical Centre in Rotterdam.

The researchers also looked at studies on the narcotics and muscle relaxants, finding that NSAIDs did not bring more relief, but did have fewer side effects.

NSAIDs have both painkilling and inflammation-quelling properties, but they can cause stomach upset or even ulcers. COX-2 inhibitor class drugs can result in fewer stomach problems, but the makers of the COX-2 inhibitor Vioxx pulled the drug from the market in 2004 after several reports of cardiovascular problems related to its use.

The review found that NSAIDs had more side effects than placebos. However, COX-2 drugs had fewer gastric side effects than other NSAIDs.

The researchers looked at “non-specific” low back pain; that is, pain not resulting from arthritis or sciatica.

“There is conflicting evidence,” the researchers said, “that NSAIDs are more effective than simple analgesics and bed rest, and moderate evidence that NSAIDS are not more effective than other drugs, physiotherapy or spinal manipulation for low back pain.”

“It varies from individual to individual,” said Jon Levine, M.D., a professor of medicine at University of California San Francisco who was not affiliated with the review. “If one NSAID does not work, you can try another. This is often a very empirical situation. If it takes care of the pain, wouldn’t you take it?”

Pain relievers also come in combination or physicians prescribe more than one at a time, Levine said.

Reference: Roelofs PDDM, et al. Non-steroidal anti-inflammatory drugs for low-back pain. Cochrane Database of Systematic Reviews 2008, Issue 1.


Story Source:

The above story is based on materials provided by Center For The Advancement of Health. The original article was written by Star Lawrence. Note: Materials may be edited for content and length.


Cite This Page:

Center For The Advancement of Health. "NSAIDs No Better Than Other Over-the-Counter Drugs for Low Back Pain." ScienceDaily. ScienceDaily, 24 January 2008. <www.sciencedaily.com/releases/2008/01/080122203145.htm>.
Center For The Advancement of Health. (2008, January 24). NSAIDs No Better Than Other Over-the-Counter Drugs for Low Back Pain. ScienceDaily. Retrieved July 30, 2014 from www.sciencedaily.com/releases/2008/01/080122203145.htm
Center For The Advancement of Health. "NSAIDs No Better Than Other Over-the-Counter Drugs for Low Back Pain." ScienceDaily. www.sciencedaily.com/releases/2008/01/080122203145.htm (accessed July 30, 2014).

Share This




More Health & Medicine News

Wednesday, July 30, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Concern Grows Over Worsening Ebola Crisis

Concern Grows Over Worsening Ebola Crisis

AFP (July 30, 2014) Pan-African airline ASKY has suspended all flights to and from the capitals of Liberia and Sierra Leone amid the worsening Ebola health crisis, which has so far caused 672 deaths in Guinea, Liberia and Sierra Leone. Duration: 00:43 Video provided by AFP
Powered by NewsLook.com
Generics Eat Into Pfizer's Sales

Generics Eat Into Pfizer's Sales

Reuters - Business Video Online (July 29, 2014) Pfizer, the world's largest drug maker, cut full-year revenue forecasts because generics could cut into sales of its anti-arthritis drug, Celebrex. Fred Katayama reports. Video provided by Reuters
Powered by NewsLook.com
Nigeria Ups Ebola Stakes on 1st Death

Nigeria Ups Ebola Stakes on 1st Death

Reuters - Business Video Online (July 29, 2014) Nigerian authorities have shut and quarantined a Lagos hospital where a Liberian man died of the Ebola virus, the first recorded case of the highly-infectious disease in Africa's most populous economy. David Pollard reports Video provided by Reuters
Powered by NewsLook.com
Running 5 Minutes A Day Might Add Years To Your Life

Running 5 Minutes A Day Might Add Years To Your Life

Newsy (July 29, 2014) According to a new study, just five minutes of running or jogging a day could add years to your life. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins